about
Structure of the poly-C9 component of the complement membrane attack complexChromosome 7-centric analysis of proteomics data from a panel of human colon carcinoma cell lines.Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project.Changes in protein abundance are observed in bacterial isolates from a natural hostProteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations.Purification of basolateral integral membrane proteins by cationic colloidal silica-based apical membrane subtraction.Structural basis for substrate selection by the translocation and assembly module of the β-barrel assembly machinery.Halogenation of glycopeptide antibiotics occurs at the amino acid level during non-ribosomal peptide synthesisNeurotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming is Primarily due to U1-viperitoxin-Dr1a, a Pre-Synaptic Neurotoxin.Chlorinated Glycopeptide Antibiotic Peptide Precursors Improve Cytochrome P450-Catalyzed Cyclization Cascade Efficiency.Proteotranscriptomic measurements of E6-Associated Protein (E6AP) targets in DU145 prostate cancer cells.Proteomic Identification of Interferon-Induced Proteins with Tetratricopeptide Repeats as Markers of M1 Macrophage Polarization.Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism.Tandem application of cationic colloidal silica and Triton X-114 for plasma membrane protein isolation and purification: Towards developing an MDCK protein databaseA proof-reading mechanism for non-proteinogenic amino acid incorporation into glycopeptide antibioticsEnzymatic Cascade To Evaluate the Tricyclization of Glycopeptide Antibiotic Precursor Peptides as a Prequel to Biosynthetic RedesignKistamicin biosynthesis reveals the biosynthetic requirements for production of highly crosslinked glycopeptide antibiotics
P50
Q28115911-4EA44BD9-5FFF-4C90-B92A-79515C92BAA2Q34514050-5384BE2A-DCC2-46D7-9B34-7965561AD21CQ35663974-728D186D-A45E-46D4-9126-31E7E4DF501DQ36158057-17E7CCB0-49AF-4FA9-9C32-1DBF7DF44571Q39491823-29EEBBBF-834B-4D8B-893A-2D7684031AEAQ39893501-4DDD56EF-1961-43F9-A6E2-86767E552CE9Q40115920-A6C6A051-C3EC-45E7-B31F-3140CDA87CAFQ42070367-7A64173E-8654-492A-90B0-1D2233AC0D1BQ48165751-586EE8DA-F525-4661-BE3F-3853CE5A07CCQ48218319-AF311029-FAA1-43A1-A1CA-327326861B7CQ49791547-7889EF8F-C909-4A9C-B3E5-C0679756D471Q52672417-5DF54D67-E805-4BD6-BB74-50AE1CEDC40BQ53265229-0528B322-7645-4C04-92EB-C96B6575710AQ57091959-14F6B1AE-CDBE-4F04-AE67-BD4BC59C525DQ89703175-7181B6F3-596D-4248-BE40-8888617D07E5Q90654469-C2F38CE4-7A34-4E90-8EC3-D23A80C1BFF2Q92733803-09F3FF19-4EE9-4E59-9E3A-EFA34796E07D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert J Goode
@ast
Robert J Goode
@en
Robert J Goode
@es
Robert J Goode
@nl
type
label
Robert J Goode
@ast
Robert J Goode
@en
Robert J Goode
@es
Robert J Goode
@nl
prefLabel
Robert J Goode
@ast
Robert J Goode
@en
Robert J Goode
@es
Robert J Goode
@nl
P106
P31
P496
0000-0002-3028-8928